Thermogelling emulsions for vascular embolization and sustained release of drugs
- 21 July 2005
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 75B (1) , 185-192
Abstract
Thermogelling emulsion system was developed to function as an embolic agent and sustained release system. PEG‐PLGA‐PEG triblock copolymer was synthesized, and blended with oily phase (Lipiodol®) to constitute the thermogelling emulsions. Because the polymer‐rich aqueous phase dramatically increases viscosity in response to temperature change, especially within the range between 20 and 30°C, the emulsions produce a stop‐flowing gel with oil droplets entrapped. Thereafter, paclitaxels were released from the oily reservoir of gelled emulsions in a controlled manner. Reduced burst effect and steady drug release with near zero‐order release kinetics were observed. Human umbilical vein endothelial cells (HUVEC) were collected from fresh umbilical cords for in vitro antiangiogenesis test. It demonstrated that the sustained release of paclitaxel from emulsions inhibited growth of HUVEC and that the IC50, calculated according to release rate, was consistent with that obtained from free drug study. In addition, the emulsions forming a depot in situ inside the injection site of the blood vessel in rabbit ear obstructed the blood flow, and being monitored under X‐ray angiography. Taken together, this study proved the feasibility of the thermogelling emulsions for vascular embolization and sustained drug release. The results presented a potential system for arterial transcatheter embolization on hepatocellular carcinoma combined with antiangiogeneic treatment. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2005Keywords
This publication has 27 references indexed in Scilit:
- Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor-1α and its significanceJournal of Hepatology, 2004
- Poly(D,L‐lactic acid‐co‐glycolic acid)‐b‐poly(ethylene glycol)‐b‐poly (D,L‐lactic acid‐co‐glycolic acid) triblock copolymer and thermoreversible phase transition in waterJournal of Biomedical Materials Research, 2002
- Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in TaiwanInternational Journal of Cancer, 2001
- Novel injectable neutral solutions of chitosan form biodegradable gels in situBiomaterials, 2000
- Experimental embolization of rabbit renal arteries to compare the effects of poly L-lactic acid microspheres with and without epirubicin release against ntraarterial injection of epirubicinCardioVascular and Interventional Radiology, 2000
- Zero-order release of lysozyme from poly(ethylene glycol)/poly(butylene terephthalate) matricesJournal of Controlled Release, 2000
- Drug release from biodegradable injectable thermosensitive hydrogel of PEG–PLGA–PEG triblock copolymersJournal of Controlled Release, 2000
- Inhibitory Effect of Oversulfated Fucoidan on Tube Formation by Human Vascular Endothelial Cells.Biological and Pharmaceutical Bulletin, 1997
- Kinetics of diffusion-mediated drug release enhanced by matrix degradationJournal of Controlled Release, 1995
- Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid)Cancer Letters, 1995